Crisnatol
Alternative Names: 770U82; BW 770; BW 77OU82; BW A770U; Crisnatol mesylateLatest Information Update: 17 Jun 2002
At a glance
- Originator Cancer Therapy and Research Center; Sanofi Winthrop
- Developer ILEX Oncology Inc
- Class Antineoplastics; Chrysenes; Propylene glycols; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Glioma; Solid tumours